MedPath

Xyrem

These highlights do not include all the information needed to use XYREM safely and effectively. See full prescribing information for XYREM. XYREM (sodium oxybate) oral solution, CIIIInitial U.S. Approval: 2002

Approved
Approval ID

926eb076-a4a8-45e4-91ef-411f0aa4f3ca

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 25, 2023

Manufacturers
FDA

Jazz Pharmaceuticals, Inc.

DUNS: 135926363

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sodium oxybate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68727-100
Application NumberNDA021196
Product Classification
M
Marketing Category
C73594
G
Generic Name
sodium oxybate
Product Specifications
Route of AdministrationORAL
Effective DateApril 28, 2017
FDA Product Classification

INGREDIENTS (1)

SODIUM OXYBATEActive
Quantity: 0.5 g in 1 mL
Code: 7G33012534
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Xyrem - FDA Drug Approval Details